Results 251 to 260 of about 175,779 (327)

The Safety of 12‐Weekly Monitoring of Neutrophil Count in Long‐Term Clozapine Patients

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Clozapine is the only truly effective treatment for refractory schizophrenia, but its use is constrained by the requirements for frequent monitoring of neutrophil counts. In the UK during the COVID‐19 pandemic, the frequency of clozapine blood monitoring was reduced in some units from 4‐weekly to 12‐weekly. We aimed to investigate
David Taylor   +3 more
wiley   +1 more source

Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma [PDF]

open access: yes, 2018
Belt, Brian A   +14 more
core   +1 more source

Discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy and Implications in Movement Disorders

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Charles Palmer   +2 more
wiley   +1 more source

Anti‐KIT Barzolvolimab for Chronic Spontaneous Urticaria

open access: yesAllergy, EarlyView.
We compared the efficacy and safety of four doses of barzolvolimab compared to placebo in reducing symptoms of chronic spontaneous urticaria in a randomized, controlled trial. Across barzolvolimab doses, rapid symptom reduction within 1 week was observed and sustained during 12 weeks.
Marcus Maurer   +11 more
wiley   +1 more source

Role for Complement C5 in Eosinophilic Inflammation of Severe Asthma

open access: yesAllergy, EarlyView.
Complement activation module, particularly C5, is positively associated with eosinophilic inflammation in severe asthma cohorts. Elevated C5 expression correlates with poor lung function improvement and persistent eosinophilic inflammation. Mouse model studies confirm that C5 exacerbates eosinophilic inflammation, highlighting its potential as a ...
Cong Dong   +217 more
wiley   +1 more source

Home - About - Disclaimer - Privacy